Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR) by 0.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,362,421 shares of the company’s stock after selling 8,726 shares during the quarter. Oscar Health comprises 1.9% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 20th largest holding. Rhenman & Partners Asset Management AB’s holdings in Oscar Health were worth $18,311,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of OSCR. State Street Corp increased its holdings in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after buying an additional 291,335 shares in the last quarter. Lingotto Investment Management LLP acquired a new position in shares of Oscar Health in the 4th quarter valued at $2,543,000. GDS Wealth Management grew its position in Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock valued at $4,648,000 after acquiring an additional 324,798 shares during the period. Victory Capital Management Inc. increased its position in Oscar Health by 296.0% during the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company’s stock worth $3,105,000 after purchasing an additional 172,706 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Oscar Health in the fourth quarter worth $5,672,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 4.6 %

Shares of NYSE:OSCR opened at $12.99 on Friday. Oscar Health, Inc. has a twelve month low of $12.25 and a twelve month high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market cap of $3.25 billion, a P/E ratio of -649.18 and a beta of 1.75. The company has a 50 day moving average of $14.60 and a 200-day moving average of $15.84.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on OSCR. Jefferies Financial Group assumed coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.